Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYalcin, Serap
dc.contributor.authorOzluer, Ozlem
dc.contributor.authorGunduz, Ufuk
dc.date.accessioned2019-11-24T20:59:13Z
dc.date.available2019-11-24T20:59:13Z
dc.date.issued2016
dc.identifier.issn2041-5990
dc.identifier.issn2041-6008
dc.identifier.urihttps://dx.doi.org/10.4155/tde-2016-0056
dc.identifier.urihttps://hdl.handle.net/20.500.12513/3237
dc.descriptionWOS: 000406665300005en_US
dc.descriptionPubMed ID: 27790949en_US
dc.description.abstractDevelopment of novel drug-delivery systems aims to specifically deliver anticancer drugs to tumor tissues and improve the efficiency of chemotherapy, while minimizing side effects of drugs on healthy tissues and organs. However, drug-delivery systems are confronted by membrane barriers and multiple drug resistance in cancer cells. In recent years, the obtained results indicate an important role of lipids, proteins and carbohydrates in apoptosis, drug transport and the process of cellular uptake of nanoparticles via endocytosis. This article discusses the hypothesis of the relationship between cell membrane structure and nanoparticles in cancer cells.en_US
dc.language.isoengen_US
dc.publisherFUTURE SCI LTDen_US
dc.relation.isversionof10.4155/tde-2016-0056en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectcanceren_US
dc.subjectcell membrane structuresen_US
dc.subjectnanoparticlesen_US
dc.titleNanoparticle-based drug delivery in cancer: the role of cell membrane structuresen_US
dc.typereviewen_US
dc.relation.journalTHERAPEUTIC DELIVERYen_US
dc.contributor.departmentKırşehir Ahi Evran Üniversitesi, Mühendislik-Mimarlık Fakültesi, Gıda Mühendisliği Bölümüen_US
dc.identifier.volume7en_US
dc.identifier.issue11en_US
dc.identifier.startpage773en_US
dc.identifier.endpage781en_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster